Cargando…
Unlocking Access To Novel Medicines In China-A Review From A Health System Perspective
China’s healthcare reform aims to provide affordable and equitable basic healthcare for all by 2020. Access to medicines is an essential part of the healthcare. The efforts of promoting access to medicines have been moving from meeting the needs of the basic healthcare, towards increasingly dedicate...
Autores principales: | Diao, Yifan, Li, Mingshuang, Huang, Zhiran, Sun, Jing, Chee, Yoke Ling, Liu, Yunali |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6927264/ https://www.ncbi.nlm.nih.gov/pubmed/31908552 http://dx.doi.org/10.2147/RMHP.S226379 |
Ejemplares similares
-
The Public Health Insurance Coverage of Novel Targeted Anticancer Medicines in China—In Favor of Whom? A Retrospective Analysis of the Insurance Claim Data
por: Li, Mingshuang, et al.
Publicado: (2021) -
How government health insurance coverage of novel anti-cancer medicines benefited patients in China – a retrospective analysis of hospital clinical data
por: Diao, Yifan, et al.
Publicado: (2021) -
Impact of public health insurance coverage of novel anticancer medication on medical expenditure and patient affordability in a provincial medical centre of China: a propensity score-matching analysis with the quasi-experimental design
por: Diao, Yifan, et al.
Publicado: (2022) -
The future of medicine unlocked
por: Le Page, Michael
Publicado: (2021) -
Unlock the innovation potential of meaning of work: An empirical study of scientific and technological workers in China
por: Liang, Kexin, et al.
Publicado: (2022)